Details of the Drug

General Information of Drug (ID: DMOHL94)

Drug Name

Nadofaragene firadenovec

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)